ts ▁in ▁the ▁area ▁of ▁ph arm aco - e conom ics ▁or ▁pres cription ▁drug ▁benefit ▁programs , ▁employ ers , ▁third - party ▁pay ers , ▁individuals ▁sk illed ▁in ▁the ▁conduct ▁and ▁interpretation ▁of ▁bi omed ical , ▁health ▁services , ▁and ▁health ▁econom ics ▁research , ▁and ▁expert ise ▁in ▁out comes ▁and ▁effect iveness ▁research ▁and ▁technology ▁assess ment . ▁M embers ▁also ▁were ▁to ▁include ▁individuals ▁representing ▁consum ers ▁and ▁the ▁elder ly . ▁Ind ividual s ▁who ▁were ▁directly ▁involved ▁in ▁providing ▁or ▁man aging ▁the ▁delivery ▁of ▁Medic are ▁items ▁and ▁services ▁were ▁not ▁to ▁const itute ▁a ▁majority ▁of ▁IP AB ' s ▁membership . ▁ ▁The ▁President ▁of ▁the ▁United ▁States ▁was ▁to ▁establish ▁a ▁system ▁for ▁public ▁dis closure ▁by ▁IP AB ▁members ▁of ▁any ▁financial ▁and ▁other ▁potential ▁conflicts ▁of ▁interest . ▁No ▁IP AB ▁member ▁was ▁to ▁be ▁engaged ▁in ▁any ▁other ▁business , ▁voc ation ▁or ▁employ ment . ▁ ▁M embers ▁were ▁to ▁be ▁paid ▁at ▁a ▁rate ▁described ▁in ▁Level ▁III ▁of ▁the ▁Executive ▁Sch edule ▁that ▁determ ines ▁pay ▁for ▁senior ▁executive ▁branch ▁officials . ▁As ▁of ▁ 2 0 1 0 , ▁this ▁was ▁$ 1 6 5 , 3 0 0 ▁a ▁year . ▁ ▁Fund ing ▁Congress ▁appropri ated ▁$ 1 5 ▁million ▁for ▁IP AB ▁in ▁ 2 0 1 2 . ▁Future ▁fund ing ▁for ▁the ▁ag ency ▁was ▁to ▁be ▁based ▁on ▁this ▁figure ▁adjust ed ▁for ▁infl ation .